Daymark Wealth Partners »

Revance Therapeutics shares owned by Daymark Wealth Partners

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Daymark Wealth Partners from 13F filings

Historical chart of Daymark Wealth Partners investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Daymark Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Daymark Wealth Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $255k 29k 8.79
2023-09-30 $275k 24k 11.47
2023-06-30 $354k 14k 25.31